Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
SURMOUNT-1 Study: In this phase 3 double-blind, randomised, controlled trial, 2539 adult patients were assigned in a 1:1:1:1 ratio to receive once-weekly, subcutaneous tirzepatide (5 mg, 10 mg, or 15 mg) or placebo for 72 weeks, including a 20-week dose-escalation period
Most patients find the process quick and manageable
Rebates are typically provided by a manufacturer to a PBM, which in turn shares rebates with health insurance payers to help reduce the cost of specific drugs. How do PBMs affect patients
The offer applies to eligible insured individuals and is not available for those with government-funded coverage
The calculator adjusts units or mL depending on whether you use a U-100 insulin syringe, tuberculin syringe, or standard syringe
US$ 25.80
US$ 23.86
US$ 29.41
US$ 26.06
US$ 21.60
US$ 29.94
